14 Best Multibagger Penny Stocks to Buy Right Now

Page 9 of 13

5. Atai Life Sciences N.V. (NASDAQ:ATAI)

Share price: $4.18

Analysts upside potential: 204%

Number of hedge fund holders: 21

Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best multibagger penny stocks to buy right now. ATAI Life Sciences holds a Strong Buy consensus from 8 analysts, with a 12‑month average target of $12.71 (range $10–$16), implying a 204% upside from the current $4.18.

On December 11, the United States Patent and Trademark Office granted Atai Life Sciences N.V. a new patent for EMP-01, an oral formulation for the treatment of social anxiety disorder. The patent covers the drug substance of EMP-01 and will provide exclusivity through 2043.

The patent identifies a highly crystalline thermodynamically stable HCl salt form of (R)-MDMA with high aqueous solubility and low hygroscopicity. The patent is poised to support the company’s strategy to develop innovative, differentiated therapies for addressing significant mental health needs.

EMP-01 is currently in clinical development for social anxiety disorder, with exploratory Phase 2a underway. The company is on course to deliver topline data in the first quarter of next year, as the drug has already demonstrated a unique dose-dependent effect profile in Phase 1 trials.

“EMP-01 is an important asset in our pipeline, and securing this patent issuance in the U.S. further strengthens our ability to advance the program while delivering meaningful value for patients and shareholders. We look forward to reporting topline data from the exploratory Phase 2a study evaluating EMP-01 in adults with social anxiety disorder in the first quarter of 2026,” said Chief Executive Officer and Co-founder of AtaiBeckley.

Atai Life Sciences N.V. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company focused on creating novel mental health treatments, primarily using psychedelic-based therapies like DMT (VLS-01) and R-MDMA (EMP-01) for conditions like treatment-resistant depression (TRD) and social anxiety, aiming for rapid, effective, and scalable solutions to address gaps in current mental healthcare.

Page 9 of 13